Hyperion Biosystems
Watertown
About Hyperion Biosystems
Founded in 2013 as an MIT “Tough Tech” spinout, Hyperion Biosystems (formerly C2Sense, Inc.) has created a suite of diagnostic devices that leverage our expertise in computer vision and physics-based algorithms to deliver exquisite performance at the lowest price. Our exceptional team of scientists and engineers have years of experience collaborating with market leaders in diagnostics and pharmaceuticals with the goal of minimizing the impact of disease and protecting people.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $37.4M
- Funding stage: Late Stage Venture
- Last round: Series C (Mar 2025)
- Website: hyperionbiosystems.com
- Phone: 3397075862
Industries & Categories
Medical Device
Social Profiles
Canonical: https://fsome.com/organization/hyperion-biosystems-58566 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.